DENVER, Feb. 12, 2025 /PRNewswire/ — Affineon Health, the leader in AI inbox solutions, today announced the launch of Affineon Embed™, a white-label program designed to help electronic health record (EHR) vendors, AI scribes, and other healthcare technology providers seamlessly integrate Affineon’s AI inbox management solution into their products.
With Affineon Embed™, healthcare tech companies can now enhance their platforms by embedding a best-in-class AI inbox that significantly reduces provider administrative burdens. Affineon’s AI inbox leverages agentic AI technology to triage, prioritize, and process incoming inbox items with unmatched accuracy and efficiency, reducing inbox volume by 30% to 80% daily and saving providers over five hours per week.
Empowering Healthcare Tech Providers with a Competitive Edge
By integrating Affineon Embed™, technology providers gain access to a scalable and fully customizable AI solution that delivers:
Designed for Key Healthcare Innovators
Affineon Embed™ is tailor-made for:
A New Era of AI-Powered Healthcare Efficiency
“Affineon Embed represents a transformative opportunity for healthcare technology companies,” said David Norris, CEO of Affineon Health. “By embedding our AI inbox, partners can immediately enhance their solutions and provide much-needed relief to providers, allowing them to focus more on patient care and less on administrative burdens.”
With administrative overload being one of the biggest drivers of provider burnout, Affineon Embed™ allows technology companies to provide a powerful, scalable, and high-value AI solution that directly addresses the needs of modern healthcare organizations.
For more information, partners can visit the Affineon Embed™ site: https://www.affineon.com/embed
About Affineon Health
Affineon Health’s AI inbox streamlines provider workflows and eases administrative burdens. Its flagship solutions improve efficiency, reduce burnout, and help healthcare providers focus on delivering high-quality patient care. Affineon integrates seamlessly with EHR and AI Scribe systems, saving providers time and enhancing the healthcare experience.
Media Inquiries:
Affineon Health
Marc Feder
marc.feder@affineon.com
www.affineon.com
SOURCE Affineon Health
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…